Review point-of-care testing for pandemic influenza and biothreats

Disaster Medicine and Public Health Preparedness

Volumn 3, Issue SUPPL.2, 2009, Pages

  Louie, Richard F ^a   Kitano, Tyler ^a   Brock, T Keith ^a   Derlet, Robert ^b   Kost, Gerald J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diagnostic challenges; H1N1; Outbreaks; POCT (point of care testing); Rapid diagnostics; Swine flu

Indexed keywords

BIOLOGICAL WARFARE; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DISASTER PLANNING; EPIDEMIC; FOOD AND DRUG ADMINISTRATION; HOSPITAL INFORMATION SYSTEM; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; ORGANIZATION AND MANAGEMENT; REVIEW; UNITED STATES; UTILIZATION REVIEW;

BIOTERRORISM; DISASTER PLANNING; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LABORATORY TECHNIQUES AND PROCEDURES; POINT-OF-CARE SYSTEMS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77649335674     PISSN: 19357893     EISSN: 193844X     Source Type: Journal    
DOI: 10.1097/DMP.0b013e3181be6dc4     Document Type: Review

References (62)

1. Kobasa D, Takada A, Shinya K, et al. Enhanced virulence of influenza A viruses with the haemaglutinin of the 1918 pandemic virus. Nature. 2004;431:703-707.
2. Hoft DF, Belshe RB. The genetic archaeology of influenza. N Engl J Med. 2004;351:2550-2551.
3. Tumpey TM, Basler CF, Aguilar PV, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science. 2005; 310:77-80.
4. Monto AS. The threat of an avian influenza pandemic. N Engl J Med. 2005;352:323-325.
5. Scholtissek C, Rohde W, von Hoyningen V, et al. On the origin of the human influenza subtypes H2N2 and H3N2. Virology. 1978;87:13-20.
6. Kawaoka Y, Krauss S, Webster RG. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol. 1989;63:4603-4608.
7. World Health Organization. Global Alert and Response: Pandemic (H1N1) 2009-Update 61. http://www.who.int/csr/don/2009-08-12/en/index.html. Accessed August 13, 2009.
8. World Health Organization. Pandemic phase descriptions. http://www.who.int/csr/disease/influenza/GIPA3AideMemoire.pdf. Accessed June 12, 2009.
9. Kman NE, Nelson RN. Infectious agents of bioterrorism: a review for emergency physicians. Emerg Med Clin North Am. 2008;26:517-547.
10. World Health Organization. Crimean-Congo Haemorrhagic Fever in Turkey. http://www.who.int/csr/don/2006-08-08b/en/index.html. Accessed June 8, 2009.
11. World Health Organization. Chikungunya in India. http://www.who.int/csr/ don/2006-10-17/en/index.html. Accessed June 8, 2009.
12. Charrel RN, Lamballerie X, Raoult D. Chikungunya outbreaks-the globalization of vectorbourne diseases. N Engl J Med. 2007;8:769-771.
13. Over 22,000 Chikungunya infections. Bangkok Post. May 29, 2009.
14. World Health Organization. End of Ebola Outbreak in the Democratic Republic of the Congo. http://www.who.int/csr/don/2009-02-17/en. Accessed June 8, 2009.
15. World Health Organization. Dengue/Dengue Haemorrhagic Fever in Brazil. http://www.who.int/csr/don/2008-04-10/en/index.html. Accessed June 8, 2009.
16. World Health Organization. Yellow Fever. http://www.who.int/mediacentre/ factsheets/fs100/en. Accessed June 8, 2009.
17. World Health Organization. Epidemic and Pandemic Alert and Response: 2002-Tularemia in Kosovo-Update 2. http://www.who.int/csr/don/2002-02-06/en/ index.html. Accessed June 8, 2009.
18. Avian influenza: Situtation in Indonesia. http://www.searo.who.int/en/ Section10/Section1027/Section2095/Section2366-13425.asp#. Accessed June 8, 2009.
19. World Health Organization. Lassa Fever. http://www.who.int/mediacentre/ factsheets/fs179/en/index.html. Accessed June 8, 2009.
20. Briese T, Janusz PT, McMullan LK, et al. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog. 2009;4:e1000455.
21. World Health Organization. Marburg Haemorrhagic Fever. http://www.who.int/mediacentre/factsheets/fs-marburg/en/index.html. Accessed June 8, 2009.
22. World Health Organization. Meningococcal Meningitis. May 2003. http://www.who.int/mediacentre/factsheets/fs141/en. Accessed June 9, 2009.
23. World Health Organization. Nipah Virus. http://www.who.int/mediacentre/ factsheets/fs262/en/index.html. Accessed June 8, 2009.
24. World Health Organization. Outbreaks of Rift Valley fever in Kenya, Somalia and United Republic of Tanzania, December 2006-April 2007. Wkly Epidemiol Rec. 2007;82:169-178.
25. World Health Organization. Epidemic and Pandemic Alert and Response: Summary of Probable SARS Cases With Onset of Illness From 1 November 2002 to 31 July 2003. http://www.who.int/csr/sars/country/table2004-04-21/en/index.html. Accessed June 8, 2009.
26. West Nile virus activity-United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:720-723.
27. World Health Organization. Plague. http://www.who.int/mediacentre/ factsheets/fs267/en/index.html. Accessed June 8, 2009.
28. Thompson WW, Weintraub E, Dhankhar P, et al. Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Virus. 2009;3:37-49.
29. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-186. (Pubitemid 36068705)
30. Centers for Disease Control and Prevention. Influenza: The Disease. http://www.cdc.gov/flu/about/disease/index.htm. Accessed June 4, 2009.
31. Derlet RW, Sandrock CE, Nguyen HH, et al. Influenza. Emedicine, April 27, 2009. http://emedicine.medscape.com/article/219557-overview. Accessed May 19, 2009.
32. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-2615.
33. Ginocchio CC, Lotlikar M, Falk L, et al. Clinical performance of the 3M Rapid Detection Flu A+B Test compared to R-mix culture, DFA, and BinaxNow Influenza A+B Test. J Clin Virol. 2009;45:146-149.
34. Ghebremedhin B, Engelmann I, Konig W, et al. Comparison of the performance of the rapid antigen detection actin Influenza A&B test and RT-PCR in different respiratory specimens. J Med Microbiol. 2009; 58:365-370.
35. Grondhal B, Puppe W, Weigl J, et al. Comparison of the BD Directigin Flu A+B kit and the Abbott TestPack RSV with a multiplex RT-PCR ELISA for rapid detection of influenza viruses and respiratory synctial virus. Clin Microbiol Infect. 2005;11:848-850.
36. Hurt AC, Alexander R, Hibbert J, et al. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol. 2007;39:132-135.
37. Cazacu AC, Demmler GJ, Neuman MA, et al. Comparison of a new lateral-flow chromatographic membrane immunoassay to viral culture for rapid detection and differentiation of Influenza A and B viruses in respiratory specimens. J Clin Microbiol. 2004;42:3661-3664.
38. Pabbaraju K, Tokaryk KL, Wong S, et al. Comparison of the Luminex xTAG respiratory viral panel with in-house nucleic acid amplification tests for diagnosis of respiratory virus infections. J Clin Microbiol. 2008; 46:3056-3062.
39. Kowalski RP, Karenchak LM, Romanowski EG, et al. Evaluation of the shell vial technique for detection of ocular adenovirus. Ophthalmology. 1999;106:1324-1327.
40. World Health Organization. WHO Recommendations on the Use of Rapid Testing for Influenza Diagnosis. July 2005. http://www.who.int/csr/disease/ avian-influenza/guidelines/RapidTestInfluenza-web.pdf. Accessed June 4, 2009.
41. Gall A, Hoffmann B, Harder T, et al. Rapid haemagglutinin subtyping and pathotyping of avian influenza viruses by a DNA microarray. J Virol Methods. 2009;160:200-205.
42. Townsend MB, Dawson ED, Mehlmann M, et al. Experimental evaluation of the FluChip diagnostic microarray for influenza virus surveillance. J Clin Microbiol. 2006;44:2863-2871. (Pubitemid 44228582)
43. Huang Y, Tang H, Duffy S, et al. Multiplex assay for simultaneously typing and subtyping influenza viruses by use of an electronic microarray. J Clin Microbiol. 2009;470:390-396.
44. World Health Organization. Influenza A(H1N1) virus resistant to oseltamivir- 2008/2009 influenza season, northern hemisphere. December 30, 2008. http://www.who.int/csr/disease/influenza/H1N120081230.pdf.Accessed June 5, 2009.
45. Gubareva L, Okomo-Adhiambo M, Deyde V, et al. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses. MMWR Morb Mortal Wkly Rep. 2009;58:433-435.
46. Sharfstein JM. Amendment to RT-PCR Detection Panel: Emergency Use of the Swine Influenza Virus Real-Time RT-PCR Detection Panel. May 2, 2009. http://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161563.htm. Accessed June 5, 2009.
47. Centers for Disease Control and Prevention. CDC Protocol of Real- Time RT-PCR for Influenza A (H1N1). http://www.who.int/csr/resources/publications/ swineflu/realtimeptpcr/en/index.html. Accessed June 4, 2009.
48. Khan AS, Sage MJ. Biological and chemical terrorism: strategic plan for preparedness and response-recommendations of the CDC Strategic Planning Workgroup. MMWR Morb Mortal Wkly Rep. 2000;49:1-14.
49. McBride MT, Masquelier D, Hindson BJ, et al. Autonomous detection of aerosolized Bacillus anthracis and Yersinia pestis. Anal Chem. 2003;75: 5293-5299.
50. Hindson BJ, Makarewicz AJ, Setlur US, et al. APDS: the autonomous pathogen detection system. Biosens Bioelectron. 2005;20:1925-1931.
51. Regan JF, Makarewicz AJ, Hindson BJ, et al. Environmental monitoring for biological threat agents using the autonomous pathogen detection system with multiplexed polymerase chain reaction. Anal Chem. 2008; 80:7422-7429.
52. Jernigan DB, Raghunathan PL, Bell BP, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis. 2002;8:1019-1028.
53. Baillie LWJ. Past, imminent and future human medical countermeasures for anthrax. J Appl Microbiol. 2006;101:594-606.
54. Shepard CW, Soriano-Gabarro M, Zell ER, et al. Antimicrobial post exposure prophylaxis for anthrax: adverse events and adherence. Emerg Infect Dis. 2002;8:1124-1132.
55. Kost GJ. Newdemics, public health, small-world networks, and point of-care testing. Point of Care. 2006;5:138-144.
56. Jamison DT, Breman JG, Measham AR, et al, eds. Priorities in Health. Washington, DC: The World Bank; 2006, p 216.
57. Louie RF, Sumner SL, Belcher S, et al. Thermal stress and point-of-care testing performance: suitability of glucose test strips and blood gas cartridges for disaster response. Disaster Med Public Health Preparedness. 2009;3:13-17.
58. FluView. 2008-2009 Influenza Season Week 22 ending June 6, 2009. www.cdc.gov/flu/weekly. Accessed June 12, 2009.
59. Bisoffi M, Hjelle B, Brown DC, et al. Detection of viral bioagents using a shear horizontal surface acoustic wave biosensor. Biosens Bioelectron. 2008;23:1397-1403.
60. Zhu H, Stybayeva G, Macal M, et al. A microdevice for multiplexed detection of T-cell-secreted cytokines. Lab Chip. 2008;8:2197-2205.
61. Kost GJ, Korte B, Beyette F, et al. The NIBIB Point of Care Technologies Research Network center themes and opportunities for exploratory POC projects. Point of Care. 2008;7:41.
62. Lam C, Waldhorn R, Toner E, et al. The prospect of using alternative medical care facilities in an influenza pandemic. Biosecur Bioterror. 2006;4:384-390.